MNOV logo

MNOV
Medicinova Inc

4,576
Mkt Cap
$68.42M
Volume
4,231.00
52W High
$1.96
52W Low
$1.17
PE Ratio
-5.69
MNOV Fundamentals
Price
$1.42
Prev Close
$1.39
Open
$1.42
50D MA
$1.42
Beta
0.50
Avg. Volume
72,376.62
EPS (Annual)
-$0.2445
P/B
1.65
Rev/Employee
$68,276.17
$33.68
Loading...
Loading...
News
all
press releases
MediciNova, Inc. (NASDAQ:MNOV) Sees Large Decrease in Short Interest
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 168,023 shares, a decline of 16.4% from the March...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
MediciNova, Inc. (NASDAQ:MNOV) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm...
MarketBeat·14d ago
News Placeholder
MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why
MediciNova (NASDAQ:MNOV) Shares Pass Above 200 Day Moving Average - Should You Sell...
MarketBeat·15d ago
News Placeholder
MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving Average - Here's What Happened
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average - Should You Sell...
MarketBeat·23d ago
News Placeholder
Maxim Group Reiterates "Buy" Rating for MediciNova (NASDAQ:MNOV)
Maxim Group reaffirmed a "buy" rating and set a $6.00 price objective on shares of MediciNova in a report on Monday...
MarketBeat·1mo ago
News Placeholder
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have received a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, two have i...
MarketBeat·1mo ago
News Placeholder
MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research
Zacks Research raised MediciNova to a "hold" rating in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Q1 Earnings Estimate for MediciNova Issued By HC Wainwright
MediciNova, Inc. (NASDAQ:MNOV - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for MediciNova in a research report issued on Monday, March 16th...
MarketBeat·1mo ago
News Placeholder
MediciNova (NASDAQ:MNOV) Now Covered by HC Wainwright
HC Wainwright initiated coverage on shares of MediciNova in a research note on Monday. They issued a "buy" rating and a $10.00 price target on the stock...
MarketBeat·2mo ago
News Placeholder
MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving Average - Should You Sell?
MediciNova (NASDAQ:MNOV) Stock Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest MNOV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.